Anti-TLR9 antibody [EPR14964-2] - BSA and Azide free
- BOND RX™ Validated
- RabMAb
- KO Validated
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Knockout Tested Rabbit Recombinant Monoclonal TLR9 antibody. Carrier free. Suitable for WB, IHC-P and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CD289, UNQ5798/PRO19605, TLR9, Toll-like receptor 9
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TLR9 antibody [EPR14964-2] - BSA and Azide free (AB250911)
Immunohistochemistry analysis of paraffin-embedded Human breast carcinoma tissue sections labelling TLR9 with ab187148 at 1/1000 dilution. The section was incubated with ab187148 for 30 mins at room temperature. Ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used as the secondary antibody. Sections were counterstained with Hematoxylin. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins. Positive staining on some immune stroma cells in human breast carcinoma tissue. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. This data was developed using ab187148, the same antibody clone in a different buffer formulation.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TLR9 antibody [EPR14964-2] - BSA and Azide free (AB250911)
Immunohistochemistry analysis of paraffin-embedded Human tonsil tissue sections labelling TLR9 with ab187148 at 1/1000 dilution. The section was incubated with ab187148 for 30 mins at room temperature. Ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used as the secondary antibody. Sections were counterstained with Hematoxylin. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins. Positive staining on some immune cells in human tonsil tissue. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. This data was developed using ab187148, the same antibody clone in a different buffer formulation.
- WB
Supplier Data
Western blot - Anti-TLR9 antibody [EPR14964-2] - BSA and Azide free (AB250911)
This data was developed using ab187148, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TLR9 antibody [EPR14964-2] (<a href='/en-us/products/primary-antibodies/tlr9-antibody-epr14964-2-ab187148'>ab187148</a>) at 1/5000 dilution
Lane 1:
Daudi cell lysate at 10 µg
Lane 2:
Raji cell lysate at 10 µg
Lane 3:
Ramos cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 115 kDa
false
- WB
Lab
Western blot - Anti-TLR9 antibody [EPR14964-2] - BSA and Azide free (AB250911)
This data was developed using ab187148, the same antibody clone in a different buffer formulation. False colour image of Western blot : Anti-TLR9 antibody [EPR14964-2] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab187148 was shown to bind specifically to TLR9. A band was observed at 140 kDa in wild-type Raji cell lysates with no signal observed at this size in TLR9 knockout cell line ab280879 (knockout cell lysate ab282939). To generate this image, wild-type and TLR9 knockout Raji cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-TLR9 antibody [EPR14964-2] (<a href='/en-us/products/primary-antibodies/tlr9-antibody-epr14964-2-ab187148'>ab187148</a>) at 1/1000 dilution
Lane 1:
Wild-type Raji cell lysate at 20 µg
Lane 2:
TLR9 knockout Raji cell lysate at 20 µg
Predicted band size: 115 kDa
Observed band size: 140 kDa
false
Related conjugates and formulations (1)
-
Anti-TLR9 antibody [EPR14964-2]
Reactivity data
Product details
ab250911 is the carrier-free version of ab187148.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TLR9 recognizes and binds to microbial DNA triggering an immune response. It is part of the Toll-like receptor family which plays an important role in the innate immune system. TLR9 engages in the formation of complexes with other molecules such as MyD88 an adaptor protein to propagate downstream signaling. This leads to the activation of transcription factors that stimulate cytokine production promoting inflammation and defense against infections.
Pathways
TLR9 participates significantly in the NF-kB activation pathway and the type I interferon signaling cascade. During these processes TLR9 interacts with proteins like IRAK4 and TRAF6. In the NF-kB pathway TLR9's role in the early immune response is coordinated with other Toll-like receptors to detect pathogen-related patterns and initiate adaptive immunity. Its influence on type I interferon signaling facilitates antiviral defense mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Journal of radiation research 64:833-841 PubMed37439405
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com